高级检索
当前位置: 首页 > 详情页

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究参与人:
研究单位: [1]Cancer Institute and Hospital, Chinese Academy of Medical Sciences [2]Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. [3]The first affiliated hospital of bengbu medical college,Bengbu,Anhui,China [4]Anhui Provincial Cancer Hospital,Hefei,Anhui,China [5]Chinese People's Liberation Army General Hospital fifth Medical Center South ward,Beijing,Beijing,China [6]Peking University People's Hospital,Beijing,Beijing,China [7]Affiliated Cancer Hospital of Chongqing University,Chongqing,Chongqing,China [8]Chinese People's Liberation Army Army Special Medical Center,Chongqing,Chongqing,China [9]Fujian Cancer Hospital,Fuzhou,Fujian,China [10]Fujian Medical University Union Hospital,Fuzhou,Fujian,China [11]The 900th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army,Fuzhou,Fujian,China [12]The first affiliated hospital of xiamen university,Xiamen,Fujian,China [13]The first Hospital of lanzhou University,Lanzhou,Gansu,China [14]Guangdong Provincial People's Hospital,Guangzhou,Guangdong,China [15]Sun Yat-sen University Cancer Center,Guangzhou,Guangdong,China [16]The First Affiliated Hospital,Sun Yat-sen University,Guangzhou,Guangdong,China [17]Shantou University School of Medicine Affiliated Cancer Hospital,Shantou,Guangdong,China [18]Cancer Hospital Chinese Academy of Medical Sciences,Shenzhen Center,Shenzhen,Guangdong,China [19]Guangxi Medical Univesity Cancer Hospital,Nanning,Guangxi,China [20]The First Afeliated Hospital of Guangxi Medical University,Nanning,Guangxi,China [21]Affiliated Hospital of Hebei University,Baoding,Hebei,China [22]Cangzhou Central Hospital,Cangzhou,Hebei,China [23]The Fourth Hospital of Hebei Medical University,Shijiazhuang,Hebei,China [24]Harbin Medical University Cancer Hospital,Harbin,Heilongjiang,China [25]AnYang Cancer Hospital,AnYang,Henan,China [26]The First Affiliated Hospital of Xinxiang Medical University,Xinxiang,Henan,China [27]Henan Provincial People's Hospital,Zhengzhou,Henan,China [28]Renmin Hospital Of Wuhan University,Wuhan,Hubei,China [29]Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan,Hubei,China [30]Zhongnan Hospital of Wuhan University,Wuhan,Hubei,China [31]Xiangyang Central Hospital,Xiangyang,Hubei,China [32]The Second Xiangya Hospital, Central South University,Changsha,Hunan,China [33]Chenzhou No.1 People's Hospital,Chenzhou,Hunan,China [34]The Central Hospital of Yongzhou,Yongzhou,Hunan,China [35]Jiangsu Cancer Hospital,Nanjing,Jiangsu,China [36]Jiangsu Province Hospital,Nanjing,Jiangsu,China [37]The Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu,China [38]Nanchang People's Hospital,Nanchang,Jiangxi,China [39]First Hospital of Jilin University,Changchun,Jilin,China [40]Jilin Cancer Hospital,Changchun,Jilin,China [41]The Second Affiliated Hospital of Dalian Medical University,Dalian,Liaoning,China [42]Liaoning cancer hospital & institute,Shenyang,Liaoning,China [43]The first hospital of china medical university,Shenyang,Liaoning,China [44]General Hospital of Ningxia Medical University,Yinchuan,Ningxia,China [45]Shandong First Medical University and Shandong Academy of Medical Sciences Shandong Cancer Hospital institute,Jinan,Shandong,China [46]Affiliated Hospital of Jining Medical University,Jining,Shandong,China [47]Linyi Cancer Hospital,Linyi,Shandong,China [48]Shanxi Cancer Hospital,Taiyuan,Shanxi,China [49]The First Affiliated Hospital of Xi'an Jiaotong University,Xian,Shanxi,China [50]West China Hospital,Sichuan University,Chengdu,Sichuan,China [51]Affiliated Hospital of Southwest Medical University,Luzhou,Sichuan,China [52]Neijiang Second People's Hospital,Neijiang,Sichuan,China [53]TianJin Medical university Cancer Institute & Hospital,TianJin,Tianjin,China [54]Yunnan Cancer Hospital,Kunming,Yunnan,China [55]The Second Affiliated Hospital Zhejiang University School of Medicine,Hangzhou,Zhejiang,China [56]Zhejiang Cancer Hospital,Hangzhou,Zhejiang,China [57]The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,Zhejiang,China [58]Henan Cancer Hospital,Zhengzhou,ZHenan,China

研究目的:
This study is designed to compare the anti-tumor activity as well as the safety and efficacy of FS-1502 versus T-DM1 in HER2-positive, unresectable locally advanced or metastatic breast cancer subjects previously treated with trastuzumab and taxane.

资源点击量:15100 今日访问量:0 总访问量:960 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北大学附属医院 技术支持:重庆聚合科技有限公司 地址:保定市莲池区裕华东路212号